44.90 USD
↗ 0.65 (1.47%)AT CLOSE (11:59 AM EDT)
Enliven Therapeutics, Inc. Common Stock
ELVNNASDAQ • USD
44.89
↘ 0.01 (0.01%)
POST MARKET (AS OF 04:58 PM EDT)
Post Market
AS OF 04:58 PM EDT
44.89
↘ 0.01 (0.01%)
Market: CLOSED
Open?$44.50
High?$46.85
Low?$44.35
Prev. Close?$44.25
Volume?629.4K
Avg. Volume?1.5M
VWAP?$45.05
Rel. Volume?0.42x
Bid / Ask
Bid?$44.10 × 400
Ask?$46.85 × 300
Spread?$2.75
Midpoint?$45.48
Valuation & Ratios
Market Cap?2.7B
Shares Out?60.9M
Float?45.4M
Float %?76.5%
P/E Ratio?N/A
P/B Ratio?5.84
EPS?-$1.73
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?28.66Strong
Quick Ratio?28.66Strong
Cash Ratio?5.97Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?5.84FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-21.7CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-22.6%WEAK▾
ROA?-21.8%WEAK▾
Cash Flow & Enterprise
FCF?$-70459000
Enterprise Value?$2.6B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
Employees
60
Market Cap
2.6B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-02-24
Address
6200 LOOKOUT ROAD
BOULDER, CO 80301
Phone: 720-647-8519
BOULDER, CO 80301
Phone: 720-647-8519